NPI: 1952356388 · ASHEVILLE, NC 28803 · Child & Adolescent Psychiatry Physician · NPI assigned 05/24/2006
Authorized official HATHAWAY, WILLIAM controls 20+ related entities in our dataset. Read more
| Authorized Official | HATHAWAY, WILLIAM (CEO) |
| NPI Enumeration Date | 05/24/2006 |
Other providers sharing the same authorized official: HATHAWAY, WILLIAM
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 25,016 | $714K |
| 2019 | 26,804 | $910K |
| 2020 | 24,920 | $887K |
| 2021 | 54,303 | $1.40M |
| 2022 | 135,845 | $2.48M |
| 2023 | 118,743 | $3.87M |
| 2024 | 127,828 | $3.97M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 49,086 | 37,970 | $8.10M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 59,440 | 44,104 | $2.37M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 47,836 | 36,470 | $1.76M |
| 99199 | Unlisted special service, procedure or report | 279,270 | 135,228 | $1.32M |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 14,028 | 10,396 | $152K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,892 | 1,345 | $109K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2,838 | 2,060 | $66K |
| 99238 | Hospital discharge day management, 30 minutes or less | 1,143 | 897 | $51K |
| 96127 | 15,741 | 10,435 | $49K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2,559 | 2,012 | $41K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 560 | 409 | $37K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 28 | 20 | $16K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 38 | 27 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 868 | 476 | $14K |
| 80305 | 3,679 | 2,607 | $14K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 105 | 70 | $13K |
| 99232 | Subsequent hospital care, per day, moderate complexity | 278 | 154 | $13K |
| 90686 | 4,241 | 3,206 | $13K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 244 | 177 | $11K |
| 36415 | Collection of venous blood by venipuncture | 7,822 | 5,925 | $11K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,649 | 1,022 | $8K |
| 0012A | 93 | 91 | $6K | |
| 0011A | 104 | 101 | $5K | |
| 99051 | 184 | 163 | $4K | |
| D0145 | Oral evaluation for a patient under three years of age | 147 | 118 | $3K |
| 0002A | 59 | 58 | $3K | |
| 0031A | 41 | 40 | $2K | |
| 92551 | 2,724 | 2,128 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 260 | 190 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 306 | 220 | $2K |
| 99215 | Prolong outpt/office vis | 249 | 210 | $2K |
| 96160 | 765 | 596 | $2K | |
| 96161 | 667 | 525 | $2K | |
| 99442 | 51 | 37 | $2K | |
| 0001A | 58 | 57 | $2K | |
| D1206 | Topical application of fluoride varnish | 146 | 117 | $1K |
| 59025 | Fetal non-stress test | 76 | 59 | $1K |
| 97802 | 35 | 27 | $1K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 14 | 14 | $1K |
| 87428 | 90 | 75 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 117 | 102 | $1K |
| 0071A | 23 | 17 | $1K | |
| 99460 | 15 | 12 | $1K | |
| 80061 | Lipid panel | 61 | 58 | $943.06 |
| 99173 | 3,203 | 2,503 | $890.27 | |
| 0240U | 20 | 15 | $855.78 | |
| 97803 | 34 | 25 | $572.67 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 27 | 18 | $537.20 |
| 83655 | 27 | 25 | $407.68 | |
| 84443 | Thyroid stimulating hormone (TSH) | 23 | 20 | $358.87 |
| 90734 | 23 | 12 | $357.04 | |
| 80053 | Comprehensive metabolic panel | 44 | 37 | $262.56 |
| 90670 | 425 | 311 | $184.68 | |
| 81025 | 33 | 24 | $160.29 | |
| 90715 | 22 | 12 | $160.04 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 19 | 16 | $156.33 |
| 85027 | 13 | 12 | $70.92 | |
| 81003 | 26 | 24 | $58.20 | |
| 85018 | 40 | 37 | $55.26 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 25 | 12 | $39.75 |
| 90633 | 35 | 26 | $32.14 | |
| 90656 | 43 | 43 | $21.79 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 25 | 12 | $1.60 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 117 | 88 | $0.00 |
| 2014F | 327 | 273 | $0.00 | |
| 91300 | 123 | 114 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 28 | 24 | $0.00 |
| 90685 | 13 | 13 | $0.00 | |
| 99000 | 5,068 | 3,938 | $0.00 | |
| 3008F | 3,392 | 2,934 | $0.00 | |
| 91301 | 215 | 203 | $0.00 | |
| 91307 | 20 | 14 | $0.00 | |
| 90698 | 52 | 36 | $0.00 | |
| 36416 | 47 | 44 | $0.00 | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 47 | 40 | $0.00 |
| 99493 | 18 | 12 | $0.00 | |
| 4037F | 78 | 67 | $0.00 | |
| 84999 | 96 | 71 | $0.00 | |
| 90680 | 12 | 12 | $0.00 | |
| 90744 | 12 | 12 | $0.00 | |
| 99441 | 19 | 12 | $0.00 | |
| 91303 | 38 | 37 | $0.00 |